Diagnosis of leishmaniasis
Author(s) -
Ehab Kotb Elmahallawy,
Antonio Sampedro Martínez,
Javier RodríguezGranger,
Yannick Hoyos-Mallecot,
Ahmad Agil,
José María NavarroMarí,
José Gutiérrez Fernández
Publication year - 2014
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.4310
Subject(s) - visceral leishmaniasis , subclinical infection , leishmaniasis , medicine , mucocutaneous zone , serology , leishmania , immunology , dermatology , virology , parasite hosting , pathology , disease , antibody , world wide web , computer science
Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses subclinical (not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and visceral) infection. This spectrum of manifestations depends on the immune status of the host, on the parasite, and on immunoinflammatory responses. Visceral leishmaniasis causes high morbidity and mortality in the developing world. Reliable laboratory methods become mandatory for accurate diagnosis, especially in immunocompromised patients such as those infected with HIV. In this article, we review the current state of the diagnostic tools for leishmaniasis, especially the serological test.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom